Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joep M.D. Galama"'
Autor:
Carla M.L. van Herpen, I. Jolanda M. de Vries, Cornelis J.A. Punt, Kris C.P. Vissers, Peter F.A. Mulders, Steven Teerenstra, Ruurd Torensma, Ingrid M.E. Desar, Joep M.D. Galama, Michel A.M. Olde Nordkamp, Joannes F.M. Jacobs, Sasja F. Mulder
Supplementary Figures S1-S3 from Cancer Patients Treated with Sunitinib or Sorafenib Have Sufficient Antibody and Cellular Immune Responses to Warrant Influenza Vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08db212ac80923055ae411946f72c552
https://doi.org/10.1158/1078-0432.22442766
https://doi.org/10.1158/1078-0432.22442766
Autor:
Carla M.L. van Herpen, I. Jolanda M. de Vries, Cornelis J.A. Punt, Kris C.P. Vissers, Peter F.A. Mulders, Steven Teerenstra, Ruurd Torensma, Ingrid M.E. Desar, Joep M.D. Galama, Michel A.M. Olde Nordkamp, Joannes F.M. Jacobs, Sasja F. Mulder
Purpose: The tyrosine kinase inhibitors sorafenib and sunitinib have efficacy in several types of cancer. Recent studies indicate that these agents affect the immune system. The way it affects the immune response to influenza vaccination is unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ea26265ce0eb60fc0bafe796f69558
https://doi.org/10.1158/1078-0432.c.6519432
https://doi.org/10.1158/1078-0432.c.6519432
Autor:
Nicolette T. C. Ursem, Joep M.D. Galama, Eric A.P. Steegers, Michael A. Gaytant, Peter H. van Gessel, Ann C. T. M. Vossen, Hajo I. J. Wildschut
Publikováno v:
European journal of obstetrics gynecology and reproductive biology, 128(1-2), 46-49. ELSEVIER SCIENCE BV
European Journal of Obstetrics & Gynecology and Reproductive Biology, 128, 1-2, pp. 46-9
European Journal of Obstetrics, Gynecology and Reproductive Biology, 128(1-2), 46-49. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 128, 46-9
European Journal of Obstetrics & Gynecology and Reproductive Biology, 128, 1-2, pp. 46-9
European Journal of Obstetrics, Gynecology and Reproductive Biology, 128(1-2), 46-49. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 128, 46-9
Contains fulltext : 51301.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To evaluate seroprevalence of anti-parvovirus B19 IgG immunoglobulins and the rate of seroconversion in seronegative pregnant women. DESIGN: Prospective assessment of a
Autor:
Cornelis J. A. Punt, Joannes F M Jacobs, Carla M.L. van Herpen, I. Jolanda M. de Vries, Ingrid M.E. Desar, Steven Teerenstra, Kris Vissers, Joep M.D. Galama, Peter F.A. Mulders, Ruurd Torensma, Sasja F. Mulder, Michel A.M. Olde Nordkamp
Publikováno v:
Clinical Cancer Research, 17, 13, pp. 4541-9
Clinical cancer research, 17(13), 4541-4549. American Association for Cancer Research Inc.
Clinical Cancer Research, 17, 4541-9
Clinical cancer research, 17(13), 4541-4549. American Association for Cancer Research Inc.
Clinical Cancer Research, 17, 4541-9
Purpose: The tyrosine kinase inhibitors sorafenib and sunitinib have efficacy in several types of cancer. Recent studies indicate that these agents affect the immune system. The way it affects the immune response to influenza vaccination is unknown.
Publikováno v:
Clinical Microbiology and Infection. (4):278-279